Search Results 211-220 of 16022 for GLP-1 agonist

  1. A Study Evaluating the Prevalence, Incidence and Predictors for Development of the Impulse Control Disorders in Patients with Prolactinomas Treated with Dopamine Agonist Therapy - Mayo Clinic

    ... Agonist Therapy. Print details. Share; Facebook · Twitter. Overview; Participation ... agonists (DA), to determine the predictors of ICD development, and to ...

  2. A Study to Evaluate the Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia - Mayo Clinic

    ... 1 trial. ... may be discontinued for four half lives prior to study assessments. - Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may ...

  3. Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc - Mayo Clinic

    Using pramlintide (Symlin), DPP-4 inhibitor, liraglutide (Victoza or other GLP-1 agonists), metformin, canagliflozin (Invokana or other SGLT2 inhibitors) at ...

  4. Insulin glargine-aglr, recombinant (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy.

  5. Evaluation of the Zone-MPC Control Algorithm Integrated into the iAPS in Pregnant Patients with Type 1 Diabetes - Mayo Clinic

    Evaluation of the Zone-MPC Control Algorithm Integrated into the iAPS in Pregnant Patients with Type 1 Diabetes ... GLP-1 agonists, Pramlintide, DPP-4 ...

  6. Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype - Mayo Clinic

    - Use of anti-obesity medications upon screening (i.e., orlistat, phentermine-topiramate, liraglutide, semaglutide, bupropion-naltrexone), metformin or GLP-1 ...

  7. Multiple endocrine neoplasia, type 1 (MEN 1) - Doctors and departments - Mayo Clinic

    Their efforts include the treatment of recurrent parathyroid tumors with percutaneous ethanol ablation, better detection of uncommon carcinoid and ...

  8. Symptoms During A Gastric Emptying Study - Mayo Clinic

    Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may affect central processing of pain; Any other condition or prior therapy that, in ...

  9. Effects of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... Treatment with GLP-1 RAs within 90 days prior to Vl. Presence of acute ...

  10. Type 1 Diabetes - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    People with high polygenic risk scores are 12 to 20 times more likely to develop type 1 diabetes. This estimate is based on data about people of African and ...